Porcine circovirus

Porcine circovirus (PCV) is a virus belonging to the family Circoviridae that affects pigs. There are two recognized types of the virus, known as Porcine circovirus type 1 (PCV1) and Porcine circovirus type 2 (PCV2). PCV1 was first identified in the 1970s and is generally considered non-pathogenic to pigs, whereas PCV2, identified in the late 1990s, is associated with several disease syndromes collectively referred to as Porcine circovirus associated diseases (PCVAD), including postweaning multisystemic wasting syndrome (PMWS), porcine dermatitis and nephropathy syndrome (PDNS), and reproductive disorders.

Etiology

Porcine circovirus is a small, non-enveloped, single-stranded DNA virus. Its genome is circular and highly conserved among different strains. PCV2, in particular, has been extensively studied due to its significant impact on the swine industry worldwide. The virus is highly resilient and can survive in the environment for extended periods, contributing to its widespread distribution and the challenge of controlling its spread.

Clinical Signs and Diagnosis

The clinical presentation of PCVAD can vary widely but often includes progressive weight loss, respiratory distress, jaundice, and increased mortality. PDNS, another condition associated with PCV2, is characterized by red, patchy skin lesions and kidney failure. Diagnosis of PCVAD typically involves a combination of clinical signs, histopathological examination of tissues, and detection of the virus or antibodies against it using polymerase chain reaction (PCR) or enzyme-linked immunosorbent assay (ELISA).

Transmission and Control

PCV is transmitted through both direct contact between pigs and indirectly through fomites and possibly vectors. The virus can also be transmitted vertically from sow to piglet. Control measures include strict biosecurity practices, vaccination, and management practices aimed at reducing stress and improving the overall health of the herd. Vaccination against PCV2 has become a standard practice in many countries and has significantly reduced the incidence and severity of PCVAD.

Vaccination and Prevention

Vaccination against PCV2 is the cornerstone of controlling PCVAD. Several commercial vaccines are available and have been shown to reduce the incidence and severity of disease, improve growth rates, and enhance overall herd health. In addition to vaccination, good management practices, including proper nutrition, sanitation, and minimizing stress through adequate space and environmental control, are critical in preventing PCVAD.

Economic Impact

The economic impact of PCVAD on the swine industry is significant, with losses attributed to reduced growth rates, increased mortality, and additional costs associated with vaccination and other control measures. The introduction of effective vaccines has helped to mitigate these losses, but the disease remains a concern due to the potential for vaccine breakdown and the emergence of new strains.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian